J&J CEO Alex Gorsky told CNBC the company needs to focus on new innovations.Alex Gorsky, CEO of Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at its annual meeting with analysts as the company tries to allay investors' concerns over its talc-based baby powder.
J&J plans to launch 10 new drugs by 2023, the company announced Wednesday. CEO Alex Gorsky said the company needs to stay focused despite the litigation. The company faces thousands of lawsuits alleging its talc baby powder products contain asbestos and caused ovarian cancer and mesothelioma. Ain December said J&J knew for decades that its baby powder contained asbestos, a story the company called "an absurd conspiracy theory."
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: